AAAAAA
Results:
1-20
|
Results: 20
Authors:
Givertz, MM
Colucci, WS
LeJemtel, TH
Gottlieb, SS
Hare, JM
Slawsky, MT
Leier, CV
Loh, E
Nicklas, JM
Lewis, BE
Citation: Mm. Givertz et al., Acute endothelin A receptor blockade in heart failure - Reply, CIRCULATION, 103(18), 2001, pp. E94-E94
Authors:
Lewis, BE
Wallis, DE
Berkowitz, SD
Matthai, WH
Fareed, J
Walenga, JM
Bartholomew, J
Sham, R
Lerner, RG
Zeigler, ZR
Rustagi, PK
Jang, IK
Rifkin, SD
Moran, J
Hursting, MJ
Kelton, JG
Citation: Be. Lewis et al., Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia, CIRCULATION, 103(14), 2001, pp. 1838-1843
Authors:
Lewis, BE
Schramm, VL
Citation: Be. Lewis et Vl. Schramm, Conformational equilibrium isotope effects in glucose by C-13 NMR spectroscopy and computational studies, J AM CHEM S, 123(7), 2001, pp. 1327-1336
Authors:
Wallis, DE
Lewis, BE
Messmore, HL
Pifarre, R
Walenga, JM
Citation: De. Wallis et al., Inadequacy of current prevention strategies for heparin-induced thrombocytopenia (vol 5, pg S16, 1999), CL APPL T-H, 6(2), 2000, pp. 114-114
Authors:
Ahmad, S
Yang, LH
Ahsan, A
Fu, K
Iqbal, O
Hoppensteadt, DA
Lewis, BE
Walenga, JM
Fareed, J
Citation: S. Ahmad et al., Pharmacokinetics of argatroban in primates: Evidence on endogenous uptake, INT ANGIOL, 19(2), 2000, pp. 126-134
Authors:
Lqbal, O
Walenga, JM
Lewis, BE
Bakhos, M
Citation: O. Lqbal et al., Bleeding complications with glycoprotein llb/llla inhibitors, DRUGS TODAY, 36(8), 2000, pp. 503-514
Authors:
Givertz, MM
Colucci, WS
LeJemtel, TH
Gottlieb, SS
Hare, JM
Slawsky, MT
Leier, CV
Loh, E
Nicklas, JM
Lewis, BE
Citation: Mm. Givertz et al., Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure, CIRCULATION, 101(25), 2000, pp. 2922-2927
Authors:
Chamberlin, JR
Lardi, AB
McKeever, LS
Wang, MH
Ramadurai, G
Grunenwald, P
Towne, WP
Grassman, ED
Leya, FS
Lewis, BE
Stein, LH
Citation: Jr. Chamberlin et al., Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro), CATHET C IN, 47(2), 1999, pp. 143-147
Authors:
Ahmad, S
Ahsan, A
George, M
Iqbal, O
Jeske, WP
McKenna, R
Lewis, BE
Walenga, JM
Fareed, J
Citation: S. Ahmad et al., Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: Potential clinical applications, CL APPL T-H, 5(4), 1999, pp. 252-258
Authors:
Wallis, DE
Lewis, BE
Messmore, HL
Pifarre, R
Walenga, JM
Citation: De. Wallis et al., Inadequacy of current prevention strategies for heparin-induced thrombocytopenia, CL APPL T-H, 5, 1999, pp. S16-S20
Authors:
Fareed, J
Lewis, BE
Callas, DD
Hoppensteadt, DA
Walenga, JM
Bick, RL
Citation: J. Fareed et al., Antithrombin agents: The new class of anticoagulant and antithrombotic drugs, CL APPL T-H, 5, 1999, pp. S45-S55
Authors:
Ahmad, S
Iqbal, O
Ahsan, A
Hoppensteadt, DA
Lewis, BE
Walenga, JM
Fareed, J
Citation: S. Ahmad et al., Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using High Performance Liquid Chromatography and functional methods, INT ANGIOL, 18(3), 1999, pp. 198-205
Authors:
Wallis, DE
Lewis, BE
Walenga, JM
Citation: De. Wallis et al., Failure of current strategies in the prevention of thrombosis in patients with heparin-induced thrombocytopenia: A clinician's perspective, SEM THROMB, 25, 1999, pp. 3-7
Authors:
Walenga, JM
Jeske, WP
Wallis, DE
Bakhos, M
Lewis, BE
Leya, F
Fareed, J
Citation: Jm. Walenga et al., Clinical experience with combined treatment of thrombin inhibitors and GPIIb IIIa inhibitors in patients with HIT, SEM THROMB, 25, 1999, pp. 77-81
Authors:
Fish, LS
Lewis, BE
Citation: Ls. Fish et Be. Lewis, Quality of life issues in the management of ovarian cancer, SEMIN ONCOL, 26(1), 1999, pp. 32-39
Authors:
Walenga, JM
Jeske, WP
Wood, JJ
Ahmad, S
Lewis, BE
Bakhos, M
Citation: Jm. Walenga et al., Laboratory tests for heparin-induced thrombocytopenia: A multicenter study, SEM HEMATOL, 36(1), 1999, pp. 22-28
Authors:
Robinson, JA
Lewis, BE
Citation: Ja. Robinson et Be. Lewis, Plasmapheresis in the management of heparin-induced thrombocytopenia, SEM HEMATOL, 36(1), 1999, pp. 29-32
Authors:
Fareed, J
Callas, D
Hoppensteadt, DA
Lewis, BE
Bick, RL
Walenga, JM
Citation: J. Fareed et al., Antithrombin agents as anticoagulants and antithrombotics: Implications indrug development, SEM HEMATOL, 36(1), 1999, pp. 42-56
Authors:
Wehrmacher, WH
Lewis, BE
Citation: Wh. Wehrmacher et Be. Lewis, It takes time to heal a broken heart, CIRCULATION, 99(12), 1999, pp. 1647-1647
Authors:
Wallis, DE
Workman, DL
Lewis, BE
Steen, L
Pifarre, R
Moran, JF
Citation: De. Wallis et al., Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia, AM J MED, 106(6), 1999, pp. 629-635
Risultati:
1-20
|